Your browser doesn't support javascript.
loading
Sickle cell allele HBB-rs334(T) is associated with decreased risk of childhood Burkitt lymphoma in East Africa.
Hong, Hyokyoung G; Gouveia, Mateus H; Ogwang, Martin D; Kerchan, Patrick; Reynolds, Steven J; Tenge, Constance N; Were, Pamela A; Kuremu, Robert T; Wekesa, Walter N; Masalu, Nestory; Kawira, Esther; Kinyera, Tobias; Wang, Xunde; Zhou, Jiefu; Leal, Thiago Peixoto; Otim, Isaac; Legason, Ismail D; Nabalende, Hadijah; Dhudha, Herry; Mumia, Mediatrix; Baker, Francine S; Okusolubo, Temiloluwa; Ayers, Leona W; Bhatia, Kishor; Goedert, James J; Woo, Joshua; Manning, Michelle; Cole, Nathan; Luo, Wen; Hicks, Belynda; Chagaluka, George; Johnston, W Thomas; Mutalima, Nora; Borgstein, Eric; Liomba, George N; Kamiza, Steve; Mkandawire, Nyengo; Mitambo, Collins; Molyneux, Elizabeth M; Newton, Robert; Hutchinson, Amy; Yeager, Meredith; Adeyemo, Adebowale A; Thein, Swee Lay; Rotimi, Charles N; Chanock, Stephen J; Prokunina-Olsson, Ludmila; Mbulaiteye, Sam M.
Afiliação
  • Hong HG; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
  • Gouveia MH; Center for Research on Genomics and Global Health, NHGRI, National Institutes of Health, Bethesda, Maryland, USA.
  • Ogwang MD; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
  • Kerchan P; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • Reynolds SJ; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • Tenge CN; EMBLEM Study, Kuluva Hospital, Arua, Uganda.
  • Were PA; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kuremu RT; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
  • Wekesa WN; EMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
  • Masalu N; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
  • Kawira E; EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
  • Kinyera T; EMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.
  • Wang X; EMBLEM Study, Shirati Health, Education, and Development Foundation, Shirati, Tanzania.
  • Zhou J; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
  • Leal TP; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • Otim I; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Legason ID; Department of Statistics and Probability, Michigan State University, East Lansing, Michigan, USA.
  • Nabalende H; Lerner Research Institute, Genomic Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Dhudha H; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
  • Mumia M; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • Baker FS; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • Okusolubo T; EMBLEM Study, Kuluva Hospital, Arua, Uganda.
  • Ayers LW; EMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
  • Bhatia K; EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.
  • Goedert JJ; EMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.
  • Woo J; EMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
  • Manning M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
  • Cole N; Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Luo W; Department of Pathology, The Ohio State University, Columbus, Ohio, USA.
  • Hicks B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
  • Chagaluka G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
  • Johnston WT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
  • Mutalima N; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Borgstein E; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Liomba GN; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Kamiza S; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Mkandawire N; Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Mitambo C; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
  • Molyneux EM; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
  • Newton R; Cancer Epidemiology Unit, University of Oxford, Oxford, UK.
  • Hutchinson A; Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Yeager M; Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Adeyemo AA; Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Thein SL; Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Rotimi CN; Research Department, Ministry of Health, Lilongwe, Malawi.
  • Chanock SJ; Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Prokunina-Olsson L; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
  • Mbulaiteye SM; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Am J Hematol ; 99(1): 113-123, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38009642
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traço Falciforme / Linfoma de Burkitt / Malária Falciparum / Malária Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traço Falciforme / Linfoma de Burkitt / Malária Falciparum / Malária Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos